Login Register Cart 0
Generic placeholder image

Current Signal Transduction Therapy

Editor-in-Chief

ISSN (Print): 1574-3624
ISSN (Online): 2212-389X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Chronic Kidney Disease and Urological Disorders: An Overview

Author(s): S. Lai*, A. Sciarra, F. Pierella, S. Pastore, L. Piloni, S. Salciccia, A.M. Perrotta, P. Protopapa, G. Pintus, G. Ricciuti, M. Ciccariello and M. Von Heland

Volume 15, Issue 2, 2020

Page: [223 - 231] Pages: 9

DOI: 10.2174/1574362413666180412142930

Price: $65

Abstract

Introduction: Chronic Kidney Disease (CKD) is a highly prevalent condition and it is a major risk factor for End-Stage Renal Disease (ESRD), cardiovascular disease, and premature death. Some congenital and acquired anomalies of the kidneys and lower urinary tract (CAKUT and CALUT) are well-known causes of CKD and ESRD, but often remain undiagnosed and their prevalence is underestimated. This study aims to provide an overview that considered mainly some of the major congenital and acquired urological diseases that could lead to renal clinical manifestations common even to the most widespread renal pathologies, for which often underdiagnosed.

Materials and Methods: PubMed search was conducted for available English literature describing the actual knowledge on congenital and acquired urological disorders determining acute and chronic kidney disease. Prospective and retrospective studies as well as meta-analyses and latest systematic reviews were included.

Results: Most of the studies examined and reviewed were discarded for wrong population or intervention or deemed unfit, and only 87 met the inclusion criteria for the review. The studies included in the review related to urological disorders that may determine chronic and acute kidney disease.

Conclusion: Some urological diseases, as CAKUT and CALUT, especially in adults, show symptoms, as renal failure, proteinuria and hypertension, very common to other kidney diseases, for this reason may remain undiagnosed and their prevalence is not completely known. Therefore, in doubtful cases, non-invasive and inexpensive tests, as cystourethrogram, should be made, to rule out urological disorders and if necessary, ultrasonography, urography and scintigraphy, might allow a correct and early diagnosis of these defects and thus adequate therapy, preventing or at least slowing down an evolution toward CKD and ESRD.

Keywords: Chronic kidney disease, acute renal failure, congenital anomalies of the kidney, congenital anomalies, urinary tract, urological disorders.

Graphical Abstract

[1]
Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidneys disease and decreased kidney function in the adult US population: Third NANHES. Am J Kidney Dis 2003; 41: 1-12.
[http://dx.doi.org/10.1053/ajkd.2003.50007] [PMID: 12500213]
[2]
De Nicola L, Donfrancesco C, Minutolo R, et al. Epidemiologia della MRC in Italia: Stato dell’arte e contributo dello studio CHARES. G Ital Nefrol 2011; 28(4): 401-7.
[PMID: 21809309]
[3]
Wood EG, Hand M, Briscoe DM, et al. North American Pediatric Renal Transplant Cooperative Study. Risk factors for mortality in infants and young children on dialysis. Am J Kidney Dis 2001; 37(3): 573-9.
[http://dx.doi.org/10.1053/ajkd.2001.22083] [PMID: 11228182]
[4]
Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E. KIM-1 and NGAL: New markers of obstructive nephropathy. Pediatr Nephrol 2011; 26(4): 579-86.
[http://dx.doi.org/10.1007/s00467-011-1773-5] [PMID: 21279810]
[5]
Yousefichaijan P, Dorreh F, Rafeie M, et al. Congenital anomalies of kidney and upper urinary tract in children with congenital hypothyroidism; a case-control study. J Renal Inj Prev 2015; 4(4): 120-6.
[6]
Noone D, Licht C. Chronic kidney disease: A new look at pathogenetic mechanisms and treatment options. Pediatr Nephrol 2014; 29(5): 779-92.
[http://dx.doi.org/10.1007/s00467-013-2436-5] [PMID: 23471475]
[7]
Warady BA, Chadha V. Chronic kidney disease in children: The global perspective. Pediatr Nephrol 2007; 22(12): 1999-2009.
[http://dx.doi.org/10.1007/s00467-006-0410-1] [PMID: 17310363]
[8]
Chadha V, Warady BA. Epidemiology of pediatric chronic kidney disease. Adv Chronic Kidney Dis 2005; 12(4): 343-52.
[http://dx.doi.org/10.1053/j.ackd.2005.07.013] [PMID: 16198273]
[9]
Doğan ÇS, Torun Bayram M. Renal outcome of children with unilateral renal agenesis. Turk J Pediatr 2013; 55(6): 612-5.
[PMID: 24577979]
[10]
Källen K. Maternal smoking and urinary organ malformations. Int J Epidemiol 1997; 26(3): 571-4.
[http://dx.doi.org/10.1093/ije/26.3.571] [PMID: 9222782]
[11]
Chevalier RL. Congenital urinary tract obstruction: The long view. Adv Chronic Kidney Dis 2015; 22(4): 312-9.
[http://dx.doi.org/10.1053/j.ackd.2015.01.012] [PMID: 26088076]
[12]
Rasouly HM, Lu W. Lower urinary tract development and disease. Wiley Interdiscip Rev Syst Biol Med 2013; 5(3): 307-42.
[http://dx.doi.org/10.1002/wsbm.1212] [PMID: 23408557]
[13]
Rollino C, D’Urso L, Beltrame G, Ferro M, Quattrocchio G, Quarello F. Vesicoureteral reflux in adults. G Ital Nefrol 2011; 28(6): 599-611.
[PMID: 22167611]
[14]
Reginensi A, Hoshi M, Boualia SK, Bouchard M, et al. Yap and Taz are required for Ret-dependent urinary tract morphogenesis. Development 2015; 142(15): 2696-703.
[http://dx.doi.org/10.1242/dev.122044] [PMID: 26243870]
[15]
Mendelsohn C. Using mouse models to understand normal and abnormal urogenital tract development. Organogenesis 2009; 5(1): 306-14.
[http://dx.doi.org/10.4161/org.8173] [PMID: 19568352]
[16]
Mattoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis 2011; 18(5): 348-54.
[http://dx.doi.org/10.1053/j.ackd.2011.07.006] [PMID: 21896376]
[17]
Buckley O, Geoghegan T, O’Brien J, Torreggiani WC. Vesicoureteric reflux in the adult. Br J Radiol 2007; 80(954): 392-400.
[http://dx.doi.org/10.1259/bjr/60682848] [PMID: 17684074]
[18]
Arant BS. Vesicoureteric reflux and renal injury. Am J Kidney Dis 1991; 17(5): 491-511.
[http://dx.doi.org/10.1016/S0272-6386(12)80490-2] [PMID: 2024650]
[19]
Neild GH, Thomson G, Nitsch D, Woolfson RG, Connolly JO, Woodhouse CR. Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys. BMC Nephrol 2004; 5: 12.
[http://dx.doi.org/10.1186/1471-2369-5-12]
[20]
Köhler J, Thysell H, Tencer J, Forsberg L, Hellström M. Long-term follow-up of reflux nephropathy in adults with vesicoureteral reflux- radiological and pathoanatomical analysis. Acta Radiol 2001; 42(4): 355-64.
[PMID: 11442458]
[21]
Wang H, Li Q, Liu J, Mendelsohn C, Salant DJ, Lu W. Noninvasive assessment of antenatal hydronephrosis in mice reveals a critical role for Robo2 in maintaining anti-reflux mechanism. PLoS One 2011; 6(9): e24763.
[http://dx.doi.org/10.1371/journal.pone.0024763] [PMID: 21949750]
[22]
Fan X, Li Q, Pisarek-Horowitz A, et al. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep 2012; 2(1): 52-61.
[http://dx.doi.org/10.1016/j.celrep.2012.06.002] [PMID: 22840396]
[23]
Hains DS, Schwaderer AL. Genetic variations in vesicoureteral reflux sequelae. Pathogens 2016; 5(1): 1209-21.
[http://dx.doi.org/10.3390/pathogens5010014]
[24]
Rushton HG. The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: Evolving concepts and future directions. Pediatr Nephrol 1997; 11(1): 108-20.
[http://dx.doi.org/10.1007/s004670050243] [PMID: 9035184]
[25]
Doganis D, Siafas K, Mavrikou M, et al. Does early treatment of urinary tract infection prevent renal damage? Pediatrics 2007; 120(4): e922-8.
[http://dx.doi.org/10.1542/peds.2006-2417] [PMID: 17875650]
[26]
Hamiwka LA, Midgley JP, Wade AW, Martz KL, Grisaru S. Outcomes of kidney transplantation in children with nephronophthisis: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Pediatr Transplant 2008; 12(8): 878-82.
[http://dx.doi.org/10.1111/j.1399-3046.2008.00942.x] [PMID: 19000067]
[27]
Bailey RR. The relationship of vesico-ureteric reflux to urinary tract infection and chronic pyelonephritis-reflux nephropathy. Clin Nephrol 1973; 1(3): 132-41.
[PMID: 4783715]
[28]
Dillon MJ, Goonasekera CD. Reflux nephropathy. J Am Soc Nephrol 1998; 9(12): 2377-83.
[PMID: 9848795]
[29]
Hinchliffe SA, Kreczy A, Ciftci AO, Chan YF, Judd BA, van Velzen D. Focal and segmental glomerulosclerosis in children with reflux nephropathy. Pediatr Pathol 1994; 14(2): 327-38.
[http://dx.doi.org/10.3109/15513819409024263] [PMID: 8008693]
[30]
Westland R, Schreuder MF, Bökenkamp A, Spreeuwenberg MD, van Wijk JA. Renal injury in children with a solitary functioning kidney-the KIMONO study. Nephrol Dial Transplant 2011; 26(5): 1533-41.
[http://dx.doi.org/10.1093/ndt/gfq844] [PMID: 21427076]
[31]
Saeidi B, Koralkar R, Griffin RL, Halloran B, Ambalavanan N, Askenazi DJ. Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates. Pediatr Nephrol 2015; 30(11): 2037-44.
[http://dx.doi.org/10.1007/s00467-015-3129-z] [PMID: 26001700]
[32]
Dursun H, Bayazit AK, Büyükçelik M, Soran M, Noyan A, Anarat A. Associated anomalies in children with congenital solitary functioning kidney. Pediatr Surg Int 2005; 21(6): 456-9.
[http://dx.doi.org/10.1007/s00383-005-1408-7] [PMID: 15883823]
[33]
Seeman T, Patzer L, John U, et al. Blood pressure, renal function, and proteinuria in children with unilateral renal agenesis. Kidney Blood Press Res 2006; 29(4): 210-5.
[http://dx.doi.org/10.1159/000095735] [PMID: 16960459]
[34]
Ransley PG, Risdon RA. Reflux nephropathy: Effects of antimicrobial therapy on the evolution of the early pyelonephritic scar. Kidney Int 1981; 20(6): 733-42.
[http://dx.doi.org/10.1038/ki.1981.204] [PMID: 7038262]
[35]
Vaidyanathan S, Abraham KA, Singh G, Soni B, Hughes P. Screening for proteinuria in ‘at-risk’ patients with spinal cord injuries: lessons learnt from failure. Patient Saf Surg 2014; 8: 25.
[http://dx.doi.org/10.1186/1754-9493-8-25] [PMID: 24955116]
[36]
Hadzhiyska V, Kostadinova I, Demirev A. Is there an advantage in performing a combined examination: diuretic renal scintigraphy and low dose computed tomography compared to the separate use of these methods in urolithiasis. Hell J Nucl Med 2015; 18(2): 90-2.
[PMID: 26187205]
[37]
Yiee J, Wilcox D. Abnormalities of the fetal bladder. Semin Fetal Neonatal Med 2008; 13(3): 164-70.
[http://dx.doi.org/10.1016/j.siny.2007.10.002] [PMID: 18053783]
[38]
Chen CY, Tsao TF, Chang HM, et al. Bladder agenesis and bilateral ectopic ureters draining into the vagina in a female infant: Demonstrated by MR imaging. Surg Radiol Anat 2012; 34(1): 89-92.
[http://dx.doi.org/10.1007/s00276-011-0838-2] [PMID: 21688139]
[39]
Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH. Megacystis at 10-14 weeks of gestation: Chromosomal defects and outcome according to bladder length. Ultrasound Obstet Gynecol 2003; 21(4): 338-41.
[http://dx.doi.org/10.1002/uog.81] [PMID: 12704740]
[40]
Siffel C, Correa A, Amar E, et al. Bladder ex- strophy: An epidemiologic study from the International Clearing- house for Birth Defects Surveillance and Research, and an over- view of the literature. Am J Med Genet C Semin Med Genet 2011; 157(4): 321-.
[41]
Brooks RJ, Higgins GY, Webster AC. Systematic review of randomized controlled trial quality in pediatric kidney transplantation. Pediatr Nephrol 2010; 25(12): 2383-92.
[http://dx.doi.org/10.1007/s00467-010-1595-x] [PMID: 20694479]
[42]
Ludwig M, Ching B, Reutter H, Boyadjiev SA. Bladder exstrophyepispadias complex. Birth Defects Res A Clin Mol Teratol 2009; 85(6): 509-22.
[http://dx.doi.org/10.1002/bdra.20557] [PMID: 19161161]
[43]
Ebert AK, Reutter H, Ludwig M, Rösch WH. The exstrophyepispadias complex. Orphanet J Rare Dis 2009; 4: 23.
[http://dx.doi.org/10.1186/1750-1172-4-23] [PMID: 19878548]
[44]
Levin TL, Han B, Little BP. Congenital anomalies of the male urethra. Pediatr Radiol 2007; 37(9): 851-62.
[http://dx.doi.org/10.1007/s00247-007-0495-0] [PMID: 17572890]
[45]
Kumar S, Jayant K, Barapatra Y, Rani J, Agrawal S. Giant urinary bladder diverticula presenting as epigastric mass and dyspepsia. Nephrourol 2014; 6(4)e18918.
[http://dx.doi.org/10.5812/numonthly.18918] [PMID: 25695022]
[46]
Ganesan I, Rajah S. Urological anomalies and chronic kidney disease in children with anorectal malformations. Pediatr Nephrol 2012; 27(7): 1125-30.
[http://dx.doi.org/10.1007/s00467-012-2128-6] [PMID: 22382467]
[47]
Runck LA, Method A, Bischoff A, et al. Defining the molecular pathologies in cloaca malformation: similarities between mouse and human. Dis Model Mech 2014; 7(4): 483-93.
[http://dx.doi.org/10.1242/dmm.014530] [PMID: 24524909]
[48]
Baskin LS. Hypospadias and urethral development. J Urol 2000; 163(3): 951-6.
[http://dx.doi.org/10.1016/S0022-5347(05)67861-5] [PMID: 10688029]
[49]
Duckett JW. Campbell’s Urology. 7th ed. Philadelphia, Pa: WB Saunders Co 1998; pp. 2093-119.
[50]
Valerio E, Vanzo V, Zaramella P, Salvadori S, Castagnetti M, Baraldi E. Exstrophy-epispadias complex in a newborn: Case report and review of the literature. AJP Rep 2015; 5(2): e183-7.
[http://dx.doi.org/10.1055/s-0035-1556759] [PMID: 26495181]
[51]
Thorup J, Nordenskjöld A, Hutson JM. Genetic and environmental origins of hypospadias. Curr Opin Endocrinol Diabetes Obes 2014; 21(3): 227-32.
[http://dx.doi.org/10.1097/MED.0000000000000063] [PMID: 24722170]
[52]
Källén B, Bertollini R, Castilla E, et al. A joint international study on the epidemiology of hypospadias. Acta Paediatr Scand Suppl 1986; 324: 1-52.
[http://dx.doi.org/10.1111/j.1651-2227.1986.tb14935.x] [PMID: 3471045]
[53]
Dewan PA, Pillay S, Kaye K. Correlation of the endoscopic and radiological anatomy of congenital obstruction of the posterior urethra and the external sphincter. Br J Urol 1997; 79(5): 790-6.
[http://dx.doi.org/10.1046/j.1464-410X.1997.00137.x] [PMID: 9158521]
[54]
Heikkilä J, Holmberg C, Kyllönen L, Rintala R, Taskinen S. Longterm risk of end stage renal disease in patients with posterior urethral valves. J Urol 2011; 186(6): 2392-6.
[http://dx.doi.org/10.1016/j.juro.2011.07.109] [PMID: 22014822]
[55]
Manzoni C, Valentini AL. Posterior urethral valves. Rays 2002; 27(2): 131-4.
[PMID: 12696266]
[56]
Dewan PA, Zappala SM, Ransley PG, Duffy PG. Endoscopic reappraisal of the morphology of congenital obstruction of the posterior urethra. Br J Urol 1992; 70(4): 439-44.
[http://dx.doi.org/10.1111/j.1464-410X.1992.tb15805.x] [PMID: 1450856]
[57]
Zia-ul-Miraj M. Anterior urethral valves: A rare cause of infravesical obstruction in children. J Pediatr Surg 2000; 35(4): 556-8.
[http://dx.doi.org/10.1053/jpsu.2000.0350556] [PMID: 10770380]
[58]
Paulhac P, Fourcade L, Lesaux N, Alain JL, Colombeau P. Anterior urethral valves and diverticula. BJU Int 2003; 92(5): 506-9.
[http://dx.doi.org/10.1046/j.1464-410X.2003.04380.x] [PMID: 12930408]
[59]
Goyal M, Sharma R, Gupta DK, Sharma A, Berry M. Congenital anterior urethral diverticulum: Sonographic diagnosis. J Clin Ultrasound 1996; 24(9): 543-4.
[http://dx.doi.org/10.1002/(SICI)1097- 0096(199611/12)24:9<543:AID-JCU11>3.0.CO;2-7] [PMID: 8906490]
[60]
Tang X, Lieske JC. Acute and chronic kidney injury in nephrolithiasis. Curr Opin Nephrol Hypertens 2014; 23(4): 385-90.
[http://dx.doi.org/10.1097/01.mnh.0000447017.28852.52] [PMID: 24848936]
[61]
Kaufman J, Dhakal M, Patel B, Hamburger R. Community acquired acute renal failure. Am J Kidney Dis 1991; 17(2): 191-8.
[http://dx.doi.org/10.1016/S0272-6386(12)81128-0] [PMID: 1992662]
[62]
Liaño F, Pascual J. Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int 1996; 50(3): 811-8.
[http://dx.doi.org/10.1038/ki.1996.380] [PMID: 8872955 ]
[63]
Organ M, Norman RW. Acute reversible kidney injury secondary to bilateral ureteric obstruction. Can Urol Assoc J 2011; 5(6): 392-6.
[http://dx.doi.org/10.5489/cuaj.11058] [PMID: 22154632]
[64]
Chevalier RL, Thornhill BA, Chang AY. Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney Int 2000; 58(5): 1987-95.
[http://dx.doi.org/10.1111/j.1523-1755.2000.00371.x] [PMID: 11044219]
[65]
Rabbani MA, Habib HB, Siddiqui BK, et al. Etiology of acute renal failure in a tertiary center. Saudi J Kidney Dis Transpl 2008; 19(6): 1009-14.
[PMID: 18974597]
[66]
Fahmy N, Sener A, Sabbisetti V, et al. Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controls. J Endourol 2013; 27(12): 1455-62.
[http://dx.doi.org/10.1089/end.2013.0188] [PMID: 24180435]
[67]
McAteer JA, Evan AP, Williams JC Jr, Lingeman JE. Treatment protocols to reduce renal injury during shock wave lithotripsy. Curr Opin Urol 2009; 19(2): 192-5.
[http://dx.doi.org/10.1097/MOU.0b013e32831e16e3] [PMID: 19195131]
[68]
Sheir KZ, Gad HM. Prospective study of the effects of shock wave lithotripsy on renal function: Role of post-shock wave lithotripsy obstruction. Urology 2003; 61(6): 1102-6.
[http://dx.doi.org/10.1016/S0090-4295(03)00265-6] [PMID: 12809870]
[69]
Carvalho M, Martin RL, Passos RC, Riella MC. Nephrectomy as a cause of chronic kidney disease in the treatment of urolithiasis: A case-control study. World J Urol 2013; 31(5): 1141-5.
[http://dx.doi.org/10.1007/s00345-012-0845-x] [PMID: 22373698]
[70]
Sairam K, Scoffone CM, Alken P, et al. Percutaneous nephrolithotomy and chronic kidney disease: Results from the CROES PCNL global study. J Urol 2012; 188(4): 1195-200.
[http://dx.doi.org/10.1016/j.juro.2012.06.027] [PMID: 22901573]
[71]
Mishra S, Sinha L, Ganesamoni R, Ganpule A, Sabnis RB, Desai M. Renal deterioration index: Preoperative prognostic model for renal functional outcome after treatment of bilateral obstructive urolithiasis in patients with chronic kidney disease. J Endourol 2013; 27(11): 1405-10.
[http://dx.doi.org/10.1089/end.2012.0456] [PMID: 23537205]
[72]
Herlitz LC, D’Agati VD, Markowitz GS. Crystalline nephropathies. Arch Pathol Lab Med 2012; 136(7): 713-20.
[http://dx.doi.org/10.5858/arpa.2011-0565-RA] [PMID: 22742545]
[73]
Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Soc Nephrol 2001; 12(7): 1482-92.
[PMID: 11423577]
[74]
Mulay SR, Evan A, Anders HJ. Molecular mechanisms of crystalrelated kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant 2014; 29(3): 507-14.
[http://dx.doi.org/10.1093/ndt/gft248] [PMID: 24163269]
[75]
Beall DP, Henslee HB, Webb HR, Scofield RH. Milk-alkali syndrome: A historical review and description of the modern version of the syndrome. Am J Med Sci 2006; 331(5): 233-42.
[http://dx.doi.org/10.1097/00000441-200605000-00001] [PMID: 16702792]
[76]
Jacobs TP, Bilezikian JP. Clinical review: Rare causes of hypercalcemia. J Clin Endocrinol Metab 2005; 90(11): 6316-22.
[PMID: 20936522]
[77]
Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int 2009; 76(10): 1027-34.
[http://dx.doi.org/10.1038/ki.2009.308] [PMID: 19675530]
[78]
Markowitz GS, Nasr SH, Klein P, et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004; 35(6): 675-84.
[http://dx.doi.org/10.1016/j.humpath.2003.12.005] [PMID: 15188133]
[79]
Lorenz EC, Michet CJ, Milliner DS, Lieske JC. Update on oxalate crystal disease. Curr Rheumatol Rep 2013; 15(7): 340.
[http://dx.doi.org/10.1007/s11926-013-0340-4] [PMID: 23666469]
[80]
Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P. Primary hyperoxaluria. Int J Nephrol 2011; 2011864580
[http://dx.doi.org/10.4061/2011/864580]] [PMID: 21748001]
[81]
Lamarche J, Nair R, Peguero A, Courville C. Vitamin C-induced oxalate nephropathy. Int J Nephrol 2011; 2011146927
[http://dx.doi.org/10.4061/2011/146927]] [PMID: 21603151]
[82]
Poldelski V, Johnson A, Wright S, Rosa VD, Zager RA. Ethylene glycol-mediated tubular injury: Identification of critical metabolites and injury pathways. Am J Kidney Dis 2001; 38(2): 339-48.
[http://dx.doi.org/10.1053/ajkd.2001.26099] [PMID: 11479160]
[83]
Nasr SH, D’Agati VD, Said SM, et al. Oxalate nephropathy complicating Rouxen Y Gastric Bypass: An underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008; 3(6): 1676-83.
[http://dx.doi.org/10.2215/CJN.02940608] [PMID: 18701613]
[84]
Singh A, Sarkar SR, Gaber LW, Perazella MA. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Am J Kidney Dis 2007; 49(1): 153-7.
[http://dx.doi.org/10.1053/j.ajkd.2006.10.004] [PMID: 17185156]
[85]
Sikora P, Pijanowska M, Majewski M, Bieniaś B, Borzecka H, Zajczkowska M. Acute renal failure due to bilateral xanthine urolithiasis in a boy with Lesch-Nyhan syndrome. Pediatr Nephrol 2006; 21(7): 1045-7.
[http://dx.doi.org/10.1007/s00467-006-0149-8] [PMID: 16773422]
[86]
Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol 2014; 29(6): 999-1008.
[http://dx.doi.org/10.1007/s00467-013-2549-x] [PMID: 23824181]
[87]
Berni A, Boddi M, Fattori EB, et al. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers. Am J Hypertens 2010; 23(6): 675-80.
[http://dx.doi.org/10.1038/ajh.2010.33] [PMID: 20203626]
[88]
Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 2004; 116(8): 546-54.
[http://dx.doi.org/10.1016/j.amjmed.2003.09.045] [PMID: 15063817]
[89]
Chandra M, Stokes MB, Kaskel F. Multinucleated podocytes: A diagnostic clue to cystinosis. Kidney Int 2010; 78(10): 1052.
[http://dx.doi.org/10.1038/ki.2010.341] [PMID: 21030980]
[90]
Nasr SH, Sethi S, Cornell LD, et al. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: An under-recognized cause of irreversible renal failure. Nephrol Dial Transplant 2010; 25(6): 1909-15.
[http://dx.doi.org/10.1093/ndt/gfp711] [PMID: 20064951]
[91]
Yarlagadda SG, Perazella MA. Drug-induced crystal nephropathy: An update. Expert Opin Drug Saf 2008; 7(2): 147-58.
[http://dx.doi.org/10.1517/14740338.7.2.147] [PMID: 18324877]
[92]
Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: Prevalence, mechanisms, and prevention. Am J Kidney Dis 2004; 44(5): 799-805.
[http://dx.doi.org/10.1016/S0272-6386(04)01131-X] [PMID: 15492945]
[93]
Alexander RT, Hemmelgarn BR, Wiebe N, et al. Alberta Kidney Disease Network. Kidney stones and kidney function loss: A cohort study. BMJ 2012; 345e5287 2012.
[http://dx.doi.org/10.1136/bmj.e5287] [PMID: 22936784]
[94]
El-Zoghby ZM, Lieske JC, Foley RN, et al. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 2012; 7(9): 1409-15.
[http://dx.doi.org/10.2215/CJN.03210312] [PMID: 22745275]
[95]
Chou YH, Li CC, Hsu H, et al. Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 2011; 27(7): 264-7.
[http://dx.doi.org/10.1016/j.kjms.2010.11.008] [PMID: 21757143]
[96]
Rule AD, Jacobson DJ, Roberts RO, et al. The association between benign prostatic hyperplasia and chronic kidney disease in community- dwelling men. Kidney Int 2005; 67(6): 2376-82.
[http://dx.doi.org/10.1111/j.1523-1755.2005.00344.x] [PMID: 15882282]
[97]
McConnell JD, Barry MJ, Bruskewitz RC. Agency for health care policy and research. benign prostatic hyperplasia: Diagnosis and treatment. Clin Pract Guidel Quick Ref Guide Clin 1994; (8): 1-17.
[PMID: 7507389]
[98]
Hong SK, Lee ST, Jeong SJ, et al. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int 2010; 105(10): 1424-8.
[http://dx.doi.org/10.1111/j.1464-410X.2009.08975.x] [PMID: 19874305]
[99]
Lee JH, Kwon H, Park YW, Cho IC, Min SK. Relationship of estimated glomerular filtration rate with lower urinary tract symptoms/benign prostatic hyperplasia measures in middle-aged men with moderate to severe lower urinary tract symptoms. Urology 2013; 82(6): 1381-5.
[http://dx.doi.org/10.1016/j.urology.2013.07.049] [PMID: 24063940]
[100]
Caiulo VA, Caiulo S, Gargasole C, et al. Ultrasound mass screening for congenital anomalies of the kidney and urinary tract. Pediatr Nephrol 2012; 27(6): 949-53.
[http://dx.doi.org/10.1007/s00467-011-2098-0] [PMID: 22271367]
[101]
Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E. KIM-1 and NGAL: New markers of obstructive nephropathy. Pediatr Nephrol 2011 r; 26(4): 579-86.
[http://dx.doi.org/10.1007/s00467-011-1773-5] [PMID: 21279810]
[102]
Taranta-Janusz K, Wasilewska A, Dębek W, Fiłonowicz R. Michaluk- Skutnik J.Urinary angiotensinogen as a novel marker of obstructive nephropathy in children. Acta Paediatr 2013; 102(9): e429-33.
[http://dx.doi.org/10.1111/apa.12324] [PMID: 23772991]
[103]
Becker A, Baum M. Obstructive uropathy. Early Hum Dev 2006; 82(1): 15-22.
[http://dx.doi.org/10.1016/j.earlhumdev.2005.11.002] [PMID: 16377104]
[104]
Apoku IN, Ayoola OO, Salako AA, Idowu BM. Ultrasound evaluation of obstructive uropathy and its hemodynamic responses in southwest Nigeria. Int Braz J Urol 2015; 41(3): 556-61.
[http://dx.doi.org/10.1590/S1677-5538.IBJU.2014.0197] [PMID: 26200551]
[105]
Orsal E, Seven B, Subasi ID, Ayan AK, Akkan Z. Vesicoureteral reflux in a nonfunctioning kidney detected by 99mTc-DTPA study. Jpn J Radiol 2013; 31(12): 823-5.
[http://dx.doi.org/10.1007/s11604-013-0259-8] [PMID: 24178153]
[106]
Cignarelli M, Lamacchia O, Cardinale G, De Cosmo S. Metabolic syndrome and albuminuria show an additive effect in modulating glomerular filtration rate in patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr 3(3): 139-42.
[http://dx.doi.org/10.1016/j.dsx.2009.04.011]
[107]
Banaga AS, Mohammed EB, Siddig RM, et al. Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan. BMC Res Notes 2015; 8: 502.
[108]
Chen YR, Yang Y, Wang SC, et al. Multidisciplinary care improves clinical outcome and reduces medical costs for pre-endstage renal disease in Taiwan. Nephrology 2014; 19(11): 699-707.
[http://dx.doi.org/10.1111/nep.12316] [PMID: 25066407]

Rights & Permissions Print Cite
Article Metrics
10
© 2024 Bentham Science Publishers | Privacy Policy